Home > PS Ratio > AKUMS DRUGS & PHARMACEUTICALS

AKUMS DRUGS & PHARMACEUTICALS
PS (Price/Sales) Ratio

The Current P/S Ratio of AKUMS DRUGS & PHARMACEUTICALS is 2.03.

Share Price ₹530.3Jul 25,2025
Market Cap ₹8,346.1 Cr
Sales-TTM₹4,118.2 CrTTM-Consolidated Results
Price/Sales2.03xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for AKUMS DRUGS & PHARMACEUTICALS
Please provide your vote to see the results
AKUMS DRUGS & PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of AKUMS DRUGS & PHARMACEUTICALS

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of AKUMS DRUGS & PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹8,346.1 Cr] as on Jul 25,2025

(/) Sales [ ₹4,118.2 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 2.03x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for AKUMS DRUGS & PHARMACEUTICALS , the investors are currently willing to pay '2.03 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of AKUMS DRUGS & PHARMACEUTICALS !

The chart below summarizes the trend in P/S Ratio of AKUMS DRUGS & PHARMACEUTICALS over the last five years.

Historical PS (Price/Sales) ratio chart of AKUMS DRUGS & PHARMACEUTICALS


PS Ratio Performance Analysis for AKUMS DRUGS & PHARMACEUTICALS

- AKUMS DRUGS & PHARMACEUTICALS 's latest p/e ratio is 2.03x.

- AKUMS DRUGS & PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 0.35x.

- AKUMS DRUGS & PHARMACEUTICALS 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, AKUMS DRUGS & PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 1.76x.

- AKUMS DRUGS & PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2024 of 0x.


How does AKUMS DRUGS & PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
AKUMS DRUGS & PHARMACEUTICALS 4,118.22.038,346.1
SUN PHARMACEUTICAL INDUSTRIES LTD52,578.47.75407,551.0
DIVIS LABORATORIES LTD9,360.018.77175,704.0
CIPLA LTD27,811.24.45123,675.0
TORRENT PHARMACEUTICALS LTD11,516.010.59121,925.0
DR REDDYS LABORATORIES LTD33,519.93.18106,626.0
MANKIND PHARMA LTD12,279.38.74107,363.0
ZYDUS LIFESCIENCES LTD23,241.54.2398,278.9
LUPIN LTD22,707.93.9289,109.1
AUROBINDO PHARMA LTD31,723.72.0565,180.5
ABBOTT INDIA LTD6,409.211.2071,761.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs AKUMS DRUGS & PHARMACEUTICALS 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.03x
Max industry PS 18.77x
Median industry PS 4.45x
Average industry PS 6.99x



You may also like the below Video Courses